The Next Generation of Digital Health

Innovations in healthcare are riding a wave of new, powerful tools, from artificial intelligence to personalized medicine. Our evening seminar will highlight examples of future technologies and question their potential effectiveness in the challenging US healthcare market. The panel will include perspectives from inventors, investors, entrepreneurs, and academics.

UC Santa Cruz Live in Silicon Valley: The Next Generation of Digital Health
Tuesday, February 13, 2018
6:00 - 8:30 p.m.
UC Santa Cruz Silicon Valley Campus

 
register button

$10 ticket* (ticket price will increase to $15 after February 6)
*This event is open to the public and free to UC Santa Cruz students with valid ID.

Our panelists:

David Deamer, professor at UC Santa Cruz, invented the central technology licensed by Oxford Nanopore Technology (ONT) for analyzing DNA, RNA, proteins, and small molecules. ONT has launched the MinION nanopore device, the first in a series designed for personalized medicine, crop science, and scientific research. Nanopore analysis also informs in his second research interest, which concerns the process by which nucleic acids first emerged on the early Earth prior to the origin of cellular life. His broader research interests include membrane biophysics, model membrane systems, membrane transport mechanisms, and molecular self-assembly processes. Professor Deamer is the author of Origins of Life (2010, with Jack W Szostak), First Life: Discovering the Connections Between Stars, Cells, and How Life Began (2011), and a new novel The Hunt for FOXP5: A Genomic Mystery Novel (2016, with Wallace Kaufman).

Kimberly MacPherson is the Executive Director of Health Management at the Haas School of Business and faculty in Health Policy and Management at the UC Berkeley School of Public Health. She is also the Co-Director for the Berkeley Center for Health Technology (BCHT). At UC Berkeley, Ms. MacPherson teaches graduate level courses at both Haas and SPH including Trends in Biotech/Pharma and Unlocking Digital Health Innovation. Ms. MacPherson brings over 20 years of health industry experience spanning leadership roles in operations, management consulting and strategic/business planning and product development. She is a member of the Board of Trustees for St. Francis Memorial Hospital and on the Dignity Health System Board Strategic Planning Committee in San Francisco. She holds a MBA from the Haas School of Business at U.C. Berkeley and a MPH from the School of Public Health at U.C. Berkeley.

Greg Yap, partner at Menlo Ventures, focuses on health, medical, and life science technology investments. Prior to joining Menlo, Greg served as entrepreneur-in-residence at Illumina Ventures; CEO and co-founder of PyrAmes, a digital health company; and CEO and co-founder of Biodesy, a protein analysis company. Other career highlights include tenures at Roche Diagnostics/Ventana, GE, Cellpoint Diagnostics, Affymetrix, and McKinsey & Company. Greg graduated from Princeton University, with an AB in molecular biology, and received his MBA from Stanford University’s Graduate School of Business.

Sam De Brouwer is cofounder at doc.ai, a blockchain conversational AI platform that performs deep learning computations on quantified biology to develop predictive analytics and personal health insights. The company successfully closed a token sale securities offer in October 2017 and the Neuron $NRN token will go live Spring 2018 along with the first public release of the doc.ai app. The $NRN token will be used by research sponsors to initiate data trials, for users to be compensated, for data scientists to be rewarded for their models and developers to be paid. Earlier she cofounded Scanadu Inc. in 2011 and served as its VP of communications until April 2016. Scanadu develops consumer facing mobile medical devices, with as first commercial product a 1-minute urine test using a smart phone, AI and the cloud. Prior moving into the health sector Sam started her entrepreneurial career in 1996 in Europe with the Starlab research lab. Sam is an angel investor and a mentor to early stage entrepreneurs.